Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
12.18
+0.97 (8.65%)
Mar 9, 2026, 3:33 PM EDT - Market open
Generate Biomedicines Market Cap
Generate Biomedicines has a market cap or net worth of $1.55 billion as of March 9, 2026.
Market Cap
1.55B
Enterprise Value
1.38B
1-Year Change
n/a
Ranking
Category
Stock Price
$12.18
Market Cap Chart
Since the IPO on February 27, 2026, Generate Biomedicines's market cap has decreased from $2.04B to $1.55B, a decrease of -23.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.43B | -9.96% |
| Mar 5, 2026 | 1.59B | 7.51% |
| Mar 4, 2026 | 1.48B | -2.93% |
| Mar 3, 2026 | 1.52B | -1.97% |
| Mar 2, 2026 | 1.55B | -23.94% |
| Feb 27, 2026 | 2.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kodiak Sciences | 1.54B |
| Vir Biotechnology | 1.53B |
| Ardelyx | 1.52B |
| Biohaven | 1.49B |
| Capricor Therapeutics | 1.44B |
| Rapport Therapeutics | 1.44B |
| MBX Biosciences | 1.44B |
| Monte Rosa Therapeutics | 1.41B |